These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17669350)

  • 1. [Functional proteomics in oncology: to understand more than to describe].
    Com E; Hondermarck H
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():27-30. PubMed ID: 17669350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
    Gulmann C; Sheehan KM; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2006 Apr; 208(5):595-606. PubMed ID: 16518808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer: a proteomic disease.
    Li G; Xiao Z; Liu J; Li C; Li F; Chen Z
    Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.
    Journet A; Ferro M
    Mass Spectrom Rev; 2004; 23(6):393-442. PubMed ID: 15290709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of breast carcinoma.
    Somiari RI; Somiari S; Russell S; Shriver CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
    Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
    Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells.
    Sandhu C; Connor M; Kislinger T; Slingerland J; Emili A
    J Proteome Res; 2005; 4(3):674-89. PubMed ID: 15952714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
    Hodgkinson VC; Eagle GL; Drew PJ; Lind MJ; Cawkwell L
    Cancer Lett; 2010 Aug; 294(1):13-24. PubMed ID: 20176436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of breast cancer: the quest for markers and therapeutic targets.
    Hondermarck H; Tastet C; El Yazidi-Belkoura I; Toillon RA; Le Bourhis X
    J Proteome Res; 2008 Apr; 7(4):1403-11. PubMed ID: 18311906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases.
    Zhao H; Adler KB; Bai C; Tang F; Wang X
    J Proteome Res; 2006 Apr; 5(4):743-55. PubMed ID: 16602680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma.
    Weinkauf M; Christopeit M; Hiddemann W; Dreyling M
    Electrophoresis; 2007 Dec; 28(23):4416-26. PubMed ID: 17990259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.
    Drukier AK; Ossetrova N; Schors E; Krasik G; Grigoriev I; Koenig C; Sulkowski M; Holcman J; Brown LR; Tomaszewski JE; Schnall MD; Sainsbury R; Lokshin AE; Godovac-Zimmermann J
    J Proteome Res; 2006 Aug; 5(8):1906-15. PubMed ID: 16889412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer proteomics: from biomarker discovery to signal pathway profiling.
    Bichsel VE; Liotta LA; Petricoin EF
    Cancer J; 2001; 7(1):69-78. PubMed ID: 11269650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteomics and breast cancer: new perspectives and limitations].
    Hondermarck H
    Pathol Biol (Paris); 2006 May; 54(4):194-8. PubMed ID: 16632259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.